Cited 12 times in
Korean Nationwide Surveillance of Antimicrobial Resistance in 2000 with Special Reference to Vancomycin Resistance in Enterococci, and Expanded-Spectrum Cephalosporin and Imipenem Resistance in Gram-Negative Bacilli
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 이경원 | - |
dc.date.accessioned | 2015-07-15T16:41:48Z | - |
dc.date.available | 2015-07-15T16:41:48Z | - |
dc.date.issued | 2003 | - |
dc.identifier.issn | 0513-5796 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/113415 | - |
dc.description.abstract | Antimicrobial resistance surveillance is necessary to determine the size of the problem and to guide empirical selection of antimicrobial agents for treating infected patients. The aim of this study was to analyze the results of susceptibility tests performed by hospitals participating in the Korean Nationwide Surveillance of Antimicrobial Resistance (KONSAR) program. The rates of oxacillin-resistant staphylococci, penicillin-nonsusceptible pneumococci, and ampicillin-resistant E. faecium were over 70%. Ampicillin-resistant H. influenzae increased to 68%. Expanded-spectrum cephalosporin-resistant K. pneumoniae, fluoroquinolone-resistant E. coli, and imipenem-resistant P. aeruginosa remained at 16% through 27%, depending on the species. The proportions of vancomycin-resistant E. faecium and imipenem-resistant P. aeruginosa were 18 - 24% and 19-21%, respectively, indicating the seriousness of antimicrobial resistance. In conclusion, the increasing prevalence of resistant bacteria indicates that more concerted effort is required to conserve the usefulness of precious new antimicrobial agents. | - |
dc.description.statementOfResponsibility | open | - |
dc.format.extent | 571~578 | - |
dc.relation.isPartOf | YONSEI MEDICAL JOURNAL | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Anti-Bacterial Agents/pharmacology* | - |
dc.subject.MESH | Cephalosporins/pharmacology* | - |
dc.subject.MESH | Drug Resistance, Microbial* | - |
dc.subject.MESH | Enterococcus/drug effects* | - |
dc.subject.MESH | Gram-Negative Bacteria/drug effects* | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Imipenem/pharmacology* | - |
dc.subject.MESH | Korea | - |
dc.subject.MESH | Vancomycin Resistance* | - |
dc.title | Korean Nationwide Surveillance of Antimicrobial Resistance in 2000 with Special Reference to Vancomycin Resistance in Enterococci, and Expanded-Spectrum Cephalosporin and Imipenem Resistance in Gram-Negative Bacilli | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Laboratory Medicine (진단검사의학) | - |
dc.contributor.googleauthor | Kyungwon Lee | - |
dc.contributor.googleauthor | Moon Yeun Kim | - |
dc.contributor.googleauthor | Yun Sop Chong | - |
dc.contributor.googleauthor | Tae Yeal Choi | - |
dc.contributor.googleauthor | Eui Chong Kim | - |
dc.contributor.googleauthor | Jung Oak Kang | - |
dc.contributor.googleauthor | Sung Ha Kang | - |
dc.identifier.doi | 10.3349/ymj.2003.44.4.571 | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A02649 | - |
dc.relation.journalcode | J02813 | - |
dc.identifier.eissn | 1976-2437 | - |
dc.identifier.pmid | 12950110 | - |
dc.subject.keyword | Animicrobial resistance | - |
dc.subject.keyword | Korean resistance sur-veillance | - |
dc.subject.keyword | pathogenic bacteria | - |
dc.contributor.alternativeName | Lee, Kyung Won | - |
dc.contributor.affiliatedAuthor | Lee, Kyung Won | - |
dc.rights.accessRights | free | - |
dc.citation.volume | 44 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 571 | - |
dc.citation.endPage | 578 | - |
dc.identifier.bibliographicCitation | YONSEI MEDICAL JOURNAL, Vol.44(4) : 571-578, 2003 | - |
dc.identifier.rimsid | 49245 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.